Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Health Guard (Suzhou) Biomed Technology Co. Ltd. currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are handled by 2 distinct examiners, yet they are both located within 1 distinct art unit. This indicates that while the company is interacting with multiple individuals, the prosecution is centralized within a specific administrative division of the patent office.
The busiest examiner for the portfolio is MCEVOY, THOMAS M, who is assigned 1 pending action. Given that there are 2 pending office actions in total, MCEVOY, THOMAS M manages a portion of the active workload alongside the other of the 2 distinct examiners. The presence of 2 distinct examiners for only 2 actions shows a lack of examiner concentration, even though the 1 distinct art unit suggests a narrow technical focus for the applications. Practitioners should note that the art unit provides a consistent environment for these 2 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCEVOY, THOMAS M | 1 | 70.8% | +35.5% |
| YANG, CHENG FONG | 1 | 62.8% | +22.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18935705 | OCULAR IMPLANT DELIVERY DEVICE | YANG, CHENG FONG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18937040 | OCULAR IMPLANT DELIVERY DEVICE | MCEVOY, THOMAS M | — |
| 18935705 | OCULAR IMPLANT DELIVERY DEVICE | YANG, CHENG FONG | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18937040 | OCULAR IMPLANT DELIVERY DEVICE | MCEVOY, THOMAS M | 3771 | §112 | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18935705 | OCULAR IMPLANT DELIVERY DEVICE | YANG, CHENG FONG | — | §102§103§112 | Non-Final OA | — | Pending | Nov 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial